386 related articles for article (PubMed ID: 28616085)
21. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
Nakajima S; Graham DY; Hattori T; Bamba T
Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Kim N; Kim JJ; Choe YH; Kim HS; Kim JI; Chung IS; ;
Korean J Gastroenterol; 2009 Nov; 54(5):269-78. PubMed ID: 19934608
[TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
24. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.
Garza-González E; Perez-Perez GI; Maldonado-Garza HJ; Bosques-Padilla FJ
World J Gastroenterol; 2014 Feb; 20(6):1438-49. PubMed ID: 24587620
[TBL] [Abstract][Full Text] [Related]
25. Gastric MALT lymphoma and Helicobacter pylori.
Salar A
Med Clin (Barc); 2019 Jan; 152(2):65-71. PubMed ID: 30424932
[TBL] [Abstract][Full Text] [Related]
26. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.
Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2011 Nov; 34(9):1047-62. PubMed ID: 21919927
[TBL] [Abstract][Full Text] [Related]
27. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
Park S; Ahn S; Hong M; Ko YH
Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
29. Association of Helicobacter pylori with gastroduodenal diseases.
Hirai Y; Hayashi S; Shimomura H; Oguma K; Yokota K
Jpn J Infect Dis; 1999 Oct; 52(5):183-97. PubMed ID: 10680084
[TBL] [Abstract][Full Text] [Related]
30. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary.
McMahon BJ; Bruce MG; Koch A; Goodman KJ; Tsukanov V; Mulvad G; Borresen ML; Sacco F; Barrett D; Westby S; Parkinson AJ
Epidemiol Infect; 2016 Jan; 144(2):225-33. PubMed ID: 26094936
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori and hematological disorders.
Santambrogio E; Orsucci L
Minerva Gastroenterol Dietol; 2019 Sep; 65(3):204-213. PubMed ID: 30994322
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
[TBL] [Abstract][Full Text] [Related]
34. [Generalization of Helicobacter pylori eradication therapy and its future in Japan].
Takahashi S; Tokunaga K; Tanaka A
Kansenshogaku Zasshi; 2006 May; 80(3):203-11. PubMed ID: 16780126
[TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori infection: a clinical overview.
Kandulski A; Selgrad M; Malfertheiner P
Dig Liver Dis; 2008 Aug; 40(8):619-26. PubMed ID: 18396114
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy.
Alpen B; Thiede C; Wündisch T; Bayerdörffer E; Stolte M; Neubauer A
Clin Lymphoma; 2001 Sep; 2(2):103-8. PubMed ID: 11707850
[TBL] [Abstract][Full Text] [Related]
37. Guidelines in the management of Helicobacter pylori infection in Japan.
Asaka M; Satoh K; Sugano K; Sugiyama T; Takahashi S; Fukuda Y; Ota H; Murakami K; Kimura K; Shimoyama T
Helicobacter; 2001 Sep; 6(3):177-86. PubMed ID: 11683920
[TBL] [Abstract][Full Text] [Related]
38. [Helicobacter pylori 2006: how to test, when to treat].
van der Weg B; Meyenberger Ch; Borovicka J
Praxis (Bern 1994); 2006 Sep; 95(37):1413-8. PubMed ID: 17009520
[TBL] [Abstract][Full Text] [Related]
39. Gastric MALT-Lymphoma: more than Helicobacter Pylori.
Van de Vyver G; Vandamme T; Steger PH; Staessen D
Acta Gastroenterol Belg; 2021; 84(4):657-659. PubMed ID: 34965047
[TBL] [Abstract][Full Text] [Related]
40. Faecal antigen tests in the confirmation of the effect of Helicobacter eradication therapy.
Paimela HM; Oksala NK; Kääriäinen IP; Carlson PJ; Kostiala AA; Sipponen PI
Ann Med; 2006; 38(5):352-6. PubMed ID: 16938804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
